Tozaro Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
31
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
14
Tozaro General Information
Description
Developer of a novel suite of reagents designed to support the development and manufacture of viral vectors in cell and gene therapy. The company's polymers and antibodies typically contain a single binding site for their target and can be fused to solid substrates, such as sensor surfaces, enabling hospitals to have ideal reagents for a wide range of applications, including point-of-care diagnostics and field-based testing.
Contact Information
Website
www.tozaro.comCorporate Office
- The Exchange Building
- Colworth Park, Sharnbrook
- Bedford MK44 1LQ
- England, United Kingdom
Corporate Office
- The Exchange Building
- Colworth Park, Sharnbrook
- Bedford MK44 1LQ
- England, United Kingdom
Tozaro Timeline
Tozaro Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Tozaro Comparisons
Industry
Financing
Details
Tozaro Competitors (20)
One of Tozaro’s 20 competitors is CIS Bio International, a Formerly PE-Backed company based in Saclay, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CIS Bio International | Formerly PE-Backed | Saclay, France | ||||
| ATUM (Biotechnology) | Formerly VC-backed | Newark, CA | ||||
| Adaptyv | Venture Capital-Backed | Lausanne, Switzerland | ||||
| Origene | Formerly VC-backed | Rockville, MD | ||||
| Dren Bio | Venture Capital-Backed | San Carlos, CA |
Tozaro Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Tozaro Patents
Tozaro Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026032995-A1 | Lentiviral detection and purification | Pending | 05-Aug-2024 | ||
| AU-2022346926-A1 | Detection of sars-cov-2 | Active | 20-Sep-2021 | ||
| AU-2022346926-B2 | Detection of sars-cov-2 | Active | 20-Sep-2021 | ||
| EP-4392177-A1 | Detection of sars-cov-2 | Active | 20-Sep-2021 | ||
| EP-4392177-B1 | Detection of sars-cov-2 | Active | 20-Sep-2021 | G01N33/56983 |
Tozaro Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Tozaro Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Tozaro FAQs
-
When was Tozaro founded?
Tozaro was founded in 2015.
-
Where is Tozaro headquartered?
Tozaro is headquartered in Bedford, United Kingdom.
-
What is the size of Tozaro?
Tozaro has 31 total employees.
-
What industry is Tozaro in?
Tozaro’s primary industry is Discovery Tools (Healthcare).
-
Is Tozaro a private or public company?
Tozaro is a Private company.
-
What is Tozaro’s current revenue?
The current revenue for Tozaro is .
-
How much funding has Tozaro raised over time?
Tozaro has raised $31.3M.
-
Who are Tozaro’s investors?
Mercia Asset Management, Centre for Process Innovation, National Research Council of Canada, National Research Council of Canada Industrial Research Assistance Program, and Tecrea are 5 of 15 investors who have invested in Tozaro.
-
Who are Tozaro’s competitors?
CIS Bio International, ATUM (Biotechnology), Adaptyv, Origene, and Dren Bio are some of the 20 competitors of Tozaro.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
